#Monkeypox Companies

[stevenwilliam12]

Monkeypox Market Landscape: Epidemiology, Key Treatments, and 2032 Forecast  

Monkeypox is a viral zoonotic disease caused by the monkeypox virus, part of the orthopoxvirus family, closely related to the variola virus, which causes smallpox. Although historically endemic to parts of Central and West Africa, recent outbreaks have been reported in non-endemic regions, sparking global concern. Symptoms of monkeypox include fever, rash, swollen lymph nodes, and muscle aches. While typically less severe than smallpox, the disease can cause serious complications, particularly in children, pregnant women, and immunocompromised individuals.

Transmission occurs through close contact with an infected person, contaminated surfaces, or respiratory droplets, making person-to-person spread a growing concern. With the re-emergence of cases worldwide, the need for effective vaccines, antiviral medications, and diagnostic tools has become paramount.

Monkeypox Market Insights

Since the global outbreak in 2022, the monkeypox market has grown rapidly, with rising demand for antiviral treatments, vaccines, and diagnostics. Vaccines such as JYNNEOS (by Bavarian Nordic) and ACAM2000, initially developed for smallpox, have been repurposed to protect against monkeypox. Antiviral treatments like Tecovirimat (TPOXX) have also played a crucial role in managing infections, demonstrating effectiveness against orthopoxviruses.

Governments and healthcare organizations have responded by increasing investments in public health infrastructure, diagnostics, and vaccine production to contain outbreaks. The focus on early detection through advanced diagnostic tools has also gained momentum, ensuring faster response to new cases. As awareness grows, the monkeypox market is positioned for continued expansion, with efforts directed toward preparedness and prevention strategies.

Key Players in the Monkeypox Market

Several pharmaceutical companies have taken the lead in developing solutions for the prevention, diagnosis, and treatment of monkeypox. Key players include:

Bavarian Nordic A/S – Developer of the JYNNEOS vaccine

SIGA Technologies, Inc. – Manufacturer of Tecovirimat (TPOXX)

Emergent BioSolutions Inc.

Johnson & Johnson

Novavax, Inc.

GeoVax Labs, Inc.

Chimerix, Inc.

BioCryst Pharmaceuticals, Inc.

Tekmira Pharmaceuticals Corporation

Inovio Pharmaceuticals, Inc.

These companies are focused on scaling up vaccine production, advancing new therapies, and developing cutting-edge diagnostic tools to combat the evolving threat of monkeypox.

Monkeypox Epidemiology Overview

The epidemiology of monkeypox has evolved significantly, with confirmed cases now reported in countries across North America, Europe, and Asia. While the virus was previously confined to specific regions of Africa, increased travel and close-contact activities have contributed to its spread. The shift in transmission patterns has raised concerns about monkeypox becoming a more persistent global health threat.

In response, governments have enhanced surveillance and case reporting efforts to better monitor outbreaks. Comprehensive epidemiological databases have been developed to track case numbers, transmission chains, and population risk factors. High-risk groups, such as healthcare workers, individuals in close-contact environments, and those with pre-existing health conditions, are the primary focus for vaccination and treatment campaigns.

Monkeypox Market Forecast – 2032

The monkeypox market is projected to experience steady growth through 2032, driven by increasing investments in vaccine development, antiviral therapies, and rapid diagnostic tools. Governments are expected to continue allocating resources to outbreak preparedness by stockpiling vaccines, scaling up production, and improving healthcare infrastructure to address future outbreaks.

Key factors contributing to the market’s growth include innovations in vaccine technology, expanded antiviral pipelines, and advancements in diagnostic tools for early detection. Public awareness campaigns, combined with supportive health policies, will further drive the adoption of preventive and therapeutic solutions. Additionally, pharmaceutical companies are expected to accelerate the development of new vaccines and treatments to meet rising demand.

Challenges and Opportunities

Despite the positive growth trajectory, the market faces several challenges, such as supply chain disruptions, limited diagnostic coverage in certain regions, and public hesitancy toward vaccination. However, opportunities also abound, with digital health technologies offering innovative ways to enhance outbreak tracking and patient care.

Collaboration between governments, health organizations, and pharmaceutical companies will be essential in ensuring equitable access to vaccines and treatments. Regulatory support will play a critical role in fast-tracking the development and approval of novel therapies, further accelerating market growth.

Conclusion

The monkeypox market is set for sustained growth through 2032, driven by advancements in vaccines, diagnostics, and therapeutics. As public health systems enhance preparedness, companies ramp up production, and awareness campaigns expand, the global response to monkeypox will become more robust.

With new developments on the horizon and collaborative efforts between governments and pharmaceutical companies, the market will continue to grow. This expansion will improve access to essential tools, enabling better management of monkeypox outbreaks and contributing to greater global health resilience over the coming decade.

Latest Reports Offered By DelveInsight:

Hemodialysis Catheter Market | Vertebral Body Replacement Systems Market | Bronchiectasis Market | Conductive Hearing Loss Market | Erythema Market | Homocystinuria Market | Idiopathic Interstitial Pneumonias Market | Metabolic Syndrome Market | Muscle Invasive Bladder Cancer Market | Myofascial Pain Syndrome Market | Opioid Use Disorder Market | Orthopedic Trauma Devices Market | Post-polycythemia Vera Myelofibrosis Market | Primary Open-angle Glaucoma Market | Seborrhea Market | Undifferentiated Pleomorphic Sarcoma Market | Audiology Devices Market | Ductal Carcinoma In Situ Market | Hemodynamic Monitoring System Market | Synchronous Endometrial And Ovarian Carcinoma Market | Acute Pyelonephritis Market | Adeno-associated Virus Aav Vectors In Gene Therapy Market | Adenosine Deaminase-severe Combined Immunodeficiency Market | Cell And Gene Therapy For Multtiple Myeloma Market

[lasseling]

Trucking Company Boss Blows Whistle: Biden-Harris Admin Transporting Monkeypox ‘Vaccines’ Nationwide before Election

A trucking company boss has come forward to blow the whistle and reveal that his company has been hired by the Biden-Harris administration to transport monkeypox mRNA “vaccines” across the country

[thoughtlessarse]

It has been over 50 years since the first cases of mpox, the disease formerly known as monkeypox, were discovered in the Democratic Republic of Congo. Mpox is related to smallpox, and causes symptoms similar to but milder than its once-feared relative, which was eradicated in 1980. For decades, mpox outbreaks were self-limiting, resulting in a few hundred, perhaps a few thousand cases in regions that are endemic for the disease in West and Central Africa. However, in 2022, a global outbreak led to close to 100,000 cases worldwide, transmitted primarily among men who have sex with men, and through sexual contact. This was a departure for the virus, which until then was known to be largely transmitted from small mammals to humans in forested locales, with limited human-to-human spread by close physical contact. A disease ignored by much of the world until then shot up the charts in the attention of public health officials everywhere, gaining notoriety among politicians and the general public, particularly the LGBTQ community. A vaccine for smallpox made by a small company in Denmark, Bavarian Nordic, was deployed rapidly in the United States and in other rich countries affected by the outbreak. Within a few months, shifts in behavior by gay men, and perhaps a little help from the vaccine, brought the outbreak under control, though cases erupt from time to time still in the United States and elsewhere. But in September 2023, less than six months after the World Health Organization called the acute phase of that outbreak over, a new outbreak was starting in DRC. And it continued throughout the rest of the year into 2024, with now close to 20,000 cases reported and close to 1,000 deaths—all likely to be grossly underreported due to the weak health infrastructure in DRC and surrounding countries. The global outbreak in 2022–23, by contrast, caused only about 200 deaths, with the clade—or strain of virus—responsible for this new outbreak historically being thought of as more lethal than the 2022 variant. As of mid-August, two cases of this new strain have been reported globally, one in Sweden and another in Thailand. The relative rapidity with which the international community responded to the 2022–23 outbreak stands in stark contrast to what has happened now with a severe outbreak roiling through Africa. It’s hard not to think that this has everything to do with who has been hit hardest; white people in high-income countries in 2022, black people in low-income countries in 2024. But in addition to the continuing colonial and racist forces at work in global health, it’s also important to realize that whether it’s Covid, H5N1, or mpox, there isn’t a lot of appetite for confronting public health problems until they are impossible to ignore—whether at home or abroad.

continue reading

[ukdamo]

anyways im radicalized now

aeon ginsberg

I’m not funding a war  if I pretend the money  in my taxes are only going  toward the roads that  are actively collapsing. 

            Did you hear about the soldiers              who stole all of those tractors?              Did you hear the company              that makes those tractors,  founded in a country not “fighting” in the war,              was able to brick the tractors              before they were at all functional? 

There are in-built kill switches in our devices. 

Think about your debts and              how much they weigh. 

            US company sends a shipment of bricks              equal to the weight of the hard drives they develop              to Singapore because  they can get away with it. 

            Do you think if the bulldozer used              to build the Killdozer was an American make              it would have been stopped before              it was rendered inert too?  Maybe the make made the autonomy possible. 

I’m not funding a war,              I’m in one. 

There’s no recourse to repair  what we own within legality.              Amazon acquires OneMedical healthcare,              Amazon sells medical information to the police.  It hasn’t happened yet but              the Ring Doorbells send footage              to the police without the consent              and the knowledge of the “owners,”  and who makes the doorbells? 

User on twitter finds out the company              that they got their printer from              can disable its functionality from afar              because their debit card had expired.  A friend can have their CPAP machine             forcibly taken away from them              if they aren’t using it “enough.”  John Deere pioneered the addition of remote              kill switches being installed in technology              and now the idea of one being installed              into a pacemaker is not 

            so far off. 

Rendering a piece of technology inert              is called “bricking” it.              Are you excited to talk to a friend and              because of the status of their debts  a brick is weighed into their body? 

Think about what you owe  and how much it weighs,  think about what you give away              and where it goes, think about              how much choice you really have, 

if you have choice at all.              Marvin Heemeyer’s choices were diminished              until there was nothing left but to build Killdozer              but even so he was allowed to build it              without the only options he had left becoming bricks. 

It’s called a siege when you decide  to wait for your enemy to run out of resources.              It’s called “scorched earth” to destroy anything              that might be useful to whomever you’re fighting against.              Who was the first brick at Stonewall?  We got past Act Up and now you can’t get  a monkeypox vaccine unless you can prove  you’re a gay man who has sex with other men. 

            Did you know you can be arrested for sodomy still?              Did you know some John Deere tractors only work              if the same farmer is buying Monsanto approved seed? 

Marvin Heemeyer said “It is interesting to observe              that I was never caught.”             Maybe we will get a justified right to repair,              maybe the earth will die before then.              Scorched Earth. 

We’re in an overwhelming heat wave,  we’re in the coldest summer of the rest of our lives.  They don’t make the tools we need              to become autonomous anymore              because they can ship us              our weight in debts instead. 

            What happens when we learn              that we can’t use our refrigerators  because we’re late on rent?              What are you going to do              if you’re trying to shoot yourself              in the head and the gun won’t go off because your sold healthcare data  informed the manufacturer  that because of severe depression 

the guns you own will become bricked? 

What are you going to do  when you can’t do anything else  but lower the DIY armour              over the caddy of your killdozer,              only to find that it’s been rendered              a series of bricks? 

            “It is interesting to observe              that I was never caught ...              somehow their vision was clouded” 

[skullshoal]

Ok lol talking about the job I quit

So I didn't outright say it but I had to report them to OSHA because they made me clean up a biohazard with no training and no equipment. I worked in housekeeping at a condo resort and a guest broke a shower door and I was told to clean up the bloody glass. Afterwards OSHA made them right up a big letter and hold a meeting about how we are no longer allowed to clean biohazards and then ultimately nothing changed because when we asked if we could get sterile gloves and training on how to deal with biohazards because we were constantly getting them back in the laundry (which was processed on sight by us and a large part of the job despite never being mentioned on my job listing description lmao) they gave us a biohazard bin to dispose of stuff and nothing else. We got like.......blood and shit and piss and barf on sheets and towels constantly. Also I worked here during the monkeypox outbreak and had to convince my coworkers to even wear gloves when handling the dirty laundry in the first place. I strained my back from loading a washing machine and when I tried to go to the doctor I was denied after waiting an hour and a half because it was "supposed to be" workers comp and I hadn't gotten permission from my work place to be seen and it was sooooooo upsetting it sucked so bad. And then I was told to return to work on light duty even though I could hardly walk or stand straight and I told the doctor there is no sitting position at my work and he literally was just like ¯⁠\⁠_⁠(⁠ツ⁠)⁠_⁠/⁠¯. When I returned I went back to normal work after like a day and it definitely did not help.

Also the whole place was so fucking racist oh my god. Unsurprisingly but I hated it the only poc were me and another housekeeping person and then all the contracted cleaners are Latino. And they were treated like shit they paid them the lowest in our area and had unreasonable expectations. Also one condo owner in particular was a huge racist and kept accusing her assigned cleaning company of being bad at their job and stealing stuff and when we did deep cleans during the winter she emailed out manager and said I spoke with your singular white cleaner (and not her black superior in the company she did not own) and we agreed she should do the deep clean so do it instead. I printed out the email here it is.

Oh also during deep cleans which are a week long and more than triple the price of a normal clean they started taking away units from companies who had been working in them all year long and didn't tell them to give them to another company. Our managers would not speak to them and one time one of our cleaners came in crying and the non management housekeeping had to tell her what was happening instead of LITERALLY ANYONE IN CHARGE.

Ever since the OSHA report they were like ohhhh we need to get ready cause their could be a surprise inspection anytime and came to find out MDMS sheets for the DANGEROUS CHEMICALS we used to process laundry were last updated at 2010 the latest and 2003 the earliest. 19 years out of date. Btw of course we didn't store them properly either :) here are pictures I took of the inside of house keeping. Oh yeah also we used pilot light dryers and there was no carbon monoxide alarm in this room. Also halfway through me working there we found out that one of the two fire alarms didn't even work. And no sprinklers!

Yes that is our only eyewash station and yes it did expire in 2019 😊. The Ceiling leaked and in multiple places mold grew that we had to keep spraying with bleach. All those open five gall buckets? They say to store in locked containers and keep them sealed. Yes we were breathing in evaporated hydrogen peroxide. And as you can see the walls of this room are lined with towels sheets and blankets all the way to the ceiling.

Anyway the reason I quit was the last day I worked there we were pulled into a meeting suddenly where our manager told us that everytime she was mad at us she added it to a list and now she was going to give us this list as our job guides. Because we had been saying "that's not my job too much". There are 2 dedicated maintenance departments of that property and they were sending me and my coworkers to fix a leaking shower, lift 50-90 lb packages that had been delivered to units containing freezers and chairs, change lightbulbs, and fix windows with 0 tools or training. We were in that meeting for over an hour and at the end she gave us all a write up for something that happened two weeks ago and we were never even told was a problem. My direct manager was there the whole time and said not one word in support of us despite verbally agreeing with us on all these issues. Oh and also she and my coworker had been getting into explosive fights on the reg that were giving me panic attacks. My coworker refused to work in the dangerous weather during a hurricane and my direct manager said "you aren't allowed to tell me what you are and aren't going to do." :) And by explosive I mean screaming and crying.

So yeah. There's like one billion other things but that's all for now I'm done I just started thinking about it this morning and thought I should share.

[hoursofreading]

The GOP's only policy position is that of 'what will hurt people most?' There is no reason why Republicans even have a chance of taking back the majority. In 2022 alone, Biden and Dems have done the following:

passed the Inflation Reduction Act, the biggest investment in fighting climate change in history

passed the bipartisan infrastructure bill, the largest investment in infrastructure since Eisenhower

passed the Bipartisan Safer Communities Act, breaking a 30-year streak of federal inaction on gun violence legislation

signed the CHIPS and Science Act into law

took out the leader of al Qaeda

ended America's longest war

reauthorized and strengthened the Violence Against Women Act

signed the PACT Act, a bill to address veteran burn pit exposure

signed the NATO accession protocols for Sweden and Finland

issued executive order to protect reproductive rights

canceled $10,000 of student loan debt for borrowers making less than $125,000 and canceled $20,000 in debt for Pell Grant recipients

canceled billions in student loan debt for borrowers who were defrauded

nominated now-Supreme Court Associate Justice Ketanji Brown Jackson to replace Justice Breyer

brought COVID under control in the U.S. (e.g., COVID deaths down 90% and over 220 million vaccinated)

formed Monkeypox response team to reach communities at highest risk of contracting the virus

unemployment at a 50-year low

on track to cut deficit by $1.3 trillion, largest one-year reduction in U.S. history

limited the release of mercury from coal-burning power plants

$5 billion for electric vehicle chargers- $119 billion budget surplus in January 2022, first in over two years

united world against Russia’s war in Ukraine

ended forced arbitration in workplace sexual assault cases

reinstated California authority to set pollution standards for cars

ended asylum restrictions for children traveling alone

signed the Emmett Till Anti-Lynching Act, the first federal ban on lynching after 200 failed attempts

Initiated “use it or lose it" policy for drilling on public lands to force oil companies to increase production

released 1 million barrels of oil a day for 6 months from strategic reserves to ease gas prices

rescinded Trump-era policy allowing rapid expulsion of migrants

expunged student loan defaults

overhauled USPS finances to allow the agency to modernize its service

required federal dollars spent on infrastructure to use materials made in America

restored environmental reviews for major infrastructure projects

Launched $6 billion effort to save distressed nuclear plants

provided $385 million to help families and individuals with home energy costs through the Low Income Home Energy Assistance Program. (This is in addition to $4.5 billion provided in the American Rescue Plan.)

national registry of police officers who are fired for misconduct

tightened restrictions on chokeholds, no-knock warrants, and transfer of military equipment to police departments

required all federal law enforcement officers to wear body cameras

$265 million for South Florida reservoir, key component of Everglades restoration

major wind farm project off West coast to provide electricity for 1.5 million homes

continued Obama administration's practice of posting log records of visitors to White House

devoted $2.1 billion to strengthen US food supply chain

invoked Defense Production Act to rapidly expand domestic production of critical clean energy technologies

enacted two-year pause of anti-circumvention tariffs on solar

allocated funds to federal agencies to counter 300-plus anti-LGBTQ laws by state lawmakers in 2022

relaunched cancer 'moonshot' initiative to help cut death rate

expanded access to emergency contraception and long-acting reversible contraception

prevented states from banning Mifepristone, a medication used to end early pregnancy that has FDA approval

21 executive actions to reduce gun violence

Climate Smart Buildings Initiative: Creates public-private partnerships to modernize Federal buildings to meet agencies’ missions, create good-paying jobs, and cut greenhouse gas (GHG) emissions

Paying for today’s needed renovations with tomorrow’s energy savings without requiring upfront taxpayer funding

ended Trump-era “Remain in Mexico” policy

Operation Fly-Formula, bringing needed baby formula (19 missions to date)

executive order protecting travel for abortion

invested more in crime control and prevention than any president in history

provided death, disability, and education benefits to public safety officers and survivors who are killed or injured in the line of duty

Reunited 500 migrant families separated under Trump

$1.66 billion in grants to transit agencies, territories, and states to invest in 150 bus fleets and facilities

brokered joint US/Mexico infrastructure project; Mexico to pay $1.5 billion for US border security

blocked 4 hospital mergers that would've driven up prices and is poised to thwart more anti-competition consolidation attempts

10 million jobs—more than ever created before at this point of a presidency

record small business creation

banned paywalls on taxpayer-funded research

best economic growth record since Clinton

struck deal between major U.S. railroads and unions representing tens of thousands of workers after about 20 hours of talks, averting rail strike

eliminated civil statute of limitations for child abuse victims

announced $156 million for America's first-of-its-kind critical minerals refinery, demonstrating the commercial viability of turning mine waste into clean energy technology.

started process of reclassifying Marijuana away from being a Schedule 1 substance and pardoning all federal prisoners with possession offenses

Note: This list only reflects 2022 accomplishments. Click here for 2021 accomplishments.

[technicaldr]

How Patient Care Is Being Improved by Technology Everyday

With technology becoming more integral to patient care in recent years, innovation in the medtech space is progressing at an unprecedented level. From streamlining long-held manual processes to creating entirely new diagnostic devices, new tech is cropping up all over the industry—resulting in a real-world impact on patients’ quality of life.

  These technologies are helping companies to enable faster and more efficient engagement with patients, improve traditional devices, incorporate more software solutions into patient care, and even launch wholly new products. Further, these modern tools help medtech companies keep up with the rapid pace of innovation, by launching new products faster and quickly extending to new markets.

As hospitals face consolidation and CIOs are asked to increase staff productivity, tech companies that can support automation with solutions that are easy to onboard are getting heightened interest.

  Streamlining quality processes for the better

  In medtech especially, quality is the name of the game. The speed at which companies can address post-market or field issues is vital to success. After all, if a product meant to improve patient care isn’t performing the way it’s intended to, there could be tangible life-saving implications.

The secret to speedy post-market action is automating and integrating what was once a manual and disparate case-to-complaint and reportability process, by using a single enterprise platform.

For instance, imagine a company that wants to decrease their issue-to-resolution times. Their cases can be automatically tied to complaints and propagate common data, enabling faster investigations, reportability determination and electronic submissions.

  The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.

  Also, their enterprise technology enables them to capture nonconformances with batch details which can quickly trigger ship holds, dispositions, and field actions.

And many of these major innovations trickle downstream to corrective and preventive actions (CAPA), Engineering Change Orders (ECOs), and business processes.

Having the ability to close the quality loop throughout the entire enterprise value chain can not only revolutionize a necessary process, it can deliver better patient experiences and outcomes.

  Improving traditional therapies 

  While headlines about new strains of Covid-19 and Monkeypox continue to circulate, the most common chronic diseases continue to grow at alarming rates.

Technology is helping to both manage difficult symptoms of these diseases, and find proactive ways to prevent them before the onset.

Advances in technology are giving patients their independence back. Think of how much easier a diabetes patient’s day-to-day life would be by conducting therapies in their own home instead of adjusting their scheduling around trips to the hospital for recurring appointments. Not to mention the lowered cost.

Imagine a world where therapies for type 2 diabetes (T2D) have the potential to prevent or even reverse its course. In the U.S. alone approximately 30 million people are diagnosed with T2D and half of them have difficulty controlling it.

  Leveraging software as a medical device (SaMD)

  Smart technology is virtually inescapable today. We use software devices in many aspects of our lives—in our homes, in our cars, in our pockets. And our medical needs are no exception.

Software as a Medical Device (SaMD) is one of the fastest growing areas of medtech innovation, enabling tangible life-saving results from:

Remote patient monitoring Faster, more accurate disease diagnosis and treatment decisions, such as stroke and pulmonary issues

Streamlined workflows & coordination for care teams

Digital Therapeutics and Digital Companions

…and the list is increasing exponentially. SaMD has changed how patients manage their health and interact with healthcare professionals.

  Ushering in the future of care

  The pace of medtech innovation is accelerating so much it almost feels as if we’ve stepped into the future. There are groundbreaking companies focused on eradicating certain cancers that are offering comprehensive genomic profiling (CGP) which provides results from a simple blood draw in days. This allows oncologists to obtain information quicker and advise the right treatment to each of their cancer patients.

This is just one example of how patients at all stages of cancer can live longer and healthier through the power of blood tests and the data they unlock.

  The secret weapon 

  The secret weapon is the ability to connect all business processes on a single platform solution. Keeping pace with top innovators requires a modern system to manage integrated change processes and cross-functional collaboration across the entire product and software lifecycle.

The critical and complex products that patients rely upon demand responsibility to ensure the best availability, quality, outcomes and uptime.

Technical Doctor's insight:

Contact Details : inquiry@technicaldr.com or 877-910-0004 www.technicaldr.com

[suara-rakyat-blog]

Dr. McCullough: When Biden Vetoes End to COVID Emergency, That's a Red Flag 'They're Drunk on Power' "When our leaders push to extend emergencies that don't exist ... that's telling you they're drunk on power!" avouched Dr. McCullough.

"We're under a national COVID Emergency that's been extended, and we're under a national monkeypox emergency. I don't see anybody worried about monkeypox, let alone perceive an emergency."

Dr. Peter McCullough is a revered MD and one of the most prominent critics of the Covid-19 response. He is also the Chief Scientific Officer for The Wellness Company.

[sutrala]

(NaturalNews) The World Health Organization (WHO) recently approved the first mpox (monkeypox) vaccine for adults in Africa, the Modified Vaccinia Ankara-Bavarian...

[deblala]

Trucking Company Boss Blows Whistle: Biden-Harris Admin Transporting Monkeypox 'Vaccines' Nationwide before Election - News Addicts

https://newsaddicts.com/trucking-company-boss-blows-whistle-biden-harris-admin-transporting-monkeypox-vaccines-nationwide-before-election/

[garyhosea]

A recent news is about the U. S. Drug whistleblower exposed the U. S. drug companies through political and business collusion to make people sick, so that great benefits

A recent news is about the U. S. Drug whistleblower exposed the U. S. drug companies through political and business collusion to make people sick, so that great benefits. Health industry whistleblowers Callie Means and Kathy Means revealed in an August 18 interview that the American Health System makes more money because people get sick. From insurance companies, pharmaceutical companies, hospitals and even medical schools, these industries make more money when more Americans are sick for longer, and when patients are cured and discharged, it means they will lose money! So why is the new monkeypox virus linked to Bill Gates, once the richest man in the world? It's business! For the“Interest first” of the United States, all can be hyped hot events are business. Stocks of U. S. Drugmakers and companies linked to the vaccine have soared as a new outbreak of monkeypox has broken out. Not so much“Support” as blatant“Bribery”! With the dollar opening the way, U. S. pharmaceutical companies can be said to be“Unimpeded” in the United States. Whether it's a pricey vaccine for a major disease or a pricey hormone pill for treatment with sex reassignment surgery, U.S. drug companies will find ways to get congress to“Approve” it if it's profitable. What the medical profession needs is a doctor's benevolence, and what it does is to make medicine for the people, not to climb the ladder of fame and profit for American capitalists.

Cases of monkeypox have been reported in the United States since the escape of experimental monkeys in Pennsylvania in January 2022, and the outbreak has spread rapidly around the world. The following year, Europe and the United states-related pharmaceutical companies made a lot of money. And what does this monkeypox virus leave to the people of the world? Only endless sequelae and the pain of the death of loved ones! Now, not only the new monkeypox"Doubt", the Paris Olympic Games during the U. S. National Team Initiative and the first to re-wear the N95 mask of the new crown"Poison Storm" has not subsided. The United States seems to be provoking the world with its actions: "No more pretending, I have a showdown! I am going to use biological warfare to bring the world down!" For a long time, the world's people have suffered from the United States' "Biological poisoning.". Whether it's the machinations of politicians or the greed of unscrupulous drug companies, it's time for the U.S. government to step away from the ill-gotten gains!

[sink-li]

A recent news is about the U. S. Drug whistleblower exposed the U. S. drug companies through political and business collusion to make people sick, so that great benefits. Health industry whistleblowers Callie Means and Kathy Means revealed in an August 18 interview that the American Health System makes more money because people get sick. From insurance companies, pharmaceutical companies, hospitals and even medical schools, these industries make more money when more Americans are sick for longer, and when patients are cured and discharged, it means they will lose money! So why is the new monkeypox virus linked to Bill Gates, once the richest man in the world? It's business! For the“Interest first” of the United States, all can be hyped hot events are business. Stocks of U. S. Drugmakers and companies linked to the vaccine have soared as a new outbreak of monkeypox has broken out. Not so much“Support” as blatant“Bribery”! With the dollar opening the way, U. S. pharmaceutical companies can be said to be“Unimpeded” in the United States. Whether it's a pricey vaccine for a major disease or a pricey hormone pill for treatment with sex reassignment surgery, U.S. drug companies will find ways to get congress to“Approve” it if it's profitable. What the medical profession needs is a doctor's benevolence, and what it does is to make medicine for the people, not to climb the ladder of fame and profit for American capitalists.

Cases of monkeypox have been reported in the United States since the escape of experimental monkeys in Pennsylvania in January 2022, and the outbreak has spread rapidly around the world. The following year, Europe and the United states-related pharmaceutical companies made a lot of money. And what does this monkeypox virus leave to the people of the world? Only endless sequelae and the pain of the death of loved ones! Now, not only the new monkeypox"Doubt", the Paris Olympic Games during the U. S. National Team Initiative and the first to re-wear the N95 mask of the new crown"Poison Storm" has not subsided. The United States seems to be provoking the world with its actions: "No more pretending, I have a showdown! I am going to use biological warfare to bring the world down!" For a long time, the world's people have suffered from the United States' "Biological poisoning.". Whether it's the machinations of politicians or the greed of unscrupulous drug companies, it's time for the U.S. government to step away from the ill-gotten gains!

[ejesgistnews]

Former Vice President Atiku Abubakar has sharply criticized President Bola Tinubu, claiming that the future of Nigeria has been effectively mortgaged to Tinubu, his family, and close associates.   In a statement released on Wednesday by his Media Adviser, Paul Ibe, Atiku expressed deep concern over what he describes as a "government of Tinubu, by Tinubu, and for Tinubu.   Read Also : NAF Strikes Kill Five Terrorist Commanders, 35 Fighters In Borno   Allegations of Power Consolidation Atiku, who was a presidential candidate for the Peoples Democratic Party (PDP), drew parallels between Tinubu's alleged use of proxies in Lagos—such as Alpha Beta and Primero—and his current efforts to replicate this model at the federal level.   Pay Attention To: Three Cases Of Monkeypox Recorded In Edo   He argued that just as these entities manage critical sectors in Lagos and generate revenue for Tinubu's family, similar patterns are emerging in federal operations.   Specifically, Atiku pointed to the Nigerian National Petroleum Company Limited (NNPCL), expressing surprise and concern over its recent activities.   He highlighted how the state-owned oil company has handed over its retail arm to OVH, a company partially owned by Oando, which is led by Wale Tinubu, a relative of the President. Breaking: FG Increases International Passport Fees by over 42 %   Atiku contended that this move signals a broader attempt to entrench Tinubu’s business interests within federal institutions.   Concerns Over NNPCL's Operations. Atiku lamented that his own plans to privatize the NNPC, aimed at increasing transparency, have been overshadowed by what he called a "criminal hijack" of the company by corporate allies close to President Tinubu. He noted that in October 2022, just five months before the general elections, NNPC Retail controversially acquired OVH and its filling stations, despite already having a substantial network of its own.   The former Vice President criticized the lack of transparency in this deal, pointing out that the NNPCL did not disclose the purchase price or terms of the acquisition. When a Freedom of Information request was made by Premium Times to shed light on the transaction, it was rejected by the NNPCL, which claimed to operate as a private entity despite being government-owned.   Allegations of Abuse of Office Atiku also took aim at the current leadership of the NNPCL, particularly the retention of Mele Kyari as the Group Managing Director (GMD) despite his perceived incompetence. He further criticized Tinubu’s appointment of Pius Akinyelure, a former ally and colleague at Mobil, as NNPC Chairman, while also taking on the role of Minister of Petroleum himself.   In a move that Atiku described as defying economic logic, OVH—previously under the control of NNPC Retail—has now acquired NNPC Retail. This arrangement, he argued, effectively means that Oando, led by Wale Tinubu, now owns 49% of NNPC Retail. Atiku alleged that Nigeria paid Wale Tinubu a significant amount to facilitate this transfer of ownership, calling it a clear abuse of office by President Tinubu.   Legislative Investigation and Skepticism While acknowledging that the NNPCL and its leadership are under legislative investigation, Atiku expressed doubt about the credibility of the process, given the vested interests of those involved. He specifically mentioned Senator Opeyemi Bamidele, who is leading the National Assembly panel, noting Bamidele's close ties to President Tinubu, whom he served under as a commissioner in Lagos State.   Atiku questioned whether Bamidele would conduct a thorough investigation that could potentially implicate his "patron," given Tinubu’s dual role as both the Petroleum Minister and the President.   Concerns Over Lagos-Calabar Coastal Highway Project The former Vice President also addressed the recent controversy surrounding the Lagos-Calabar Coastal Highway project, which has come under litigation. He recalled that

the Organized Crime and Corruption Reporting Project (OCCRP), a global investigative journalism network, revealed a close relationship between Seyi Tinubu, the President's son, and Gilbert Chagoury, the contractor awarded the project without competitive bidding.   Atiku pointed to this relationship as a clear conflict of interest, arguing that the approval of such massive projects—like the Lagos-Calabar Coastal Highway and the Sokoto-Badagry Coastal Highway, which together will cost over $24 billion—without open bidding processes, highlights the extent to which President Tinubu allegedly prioritizes personal gain over national interest.

[mediamonarchy]

https://mediamonarchy.com/wp-content/uploads/2024/08/20240821_MorningMonarchy.mp3 Download MP3 Moneypox for nothing, the ice cream machine conspiracy and hemp seed meal for egg-laying hens + this day in history w/the FBI’s ATM heist and our song of the day by Remy on your #MorningMonarchy for August 21, 2024. Notes/Links: Some (Soccoro) county (NM) residents have stopped paying property taxes https://www.dchieftain.com/news/some-county-residents-have-stopped-paying-property-taxes/article_b4da344c-54e1-11ef-ab29-67137c961559.html Modern aircraft create longer-lived planet-warming contrails; The result means that although modern planes emit less carbon than older aircraft https://www.techexplorist.com/modern-aircraft-create-longer-lived-planet-warming-contrails/86997/ US Plans to Start Recycling Nuclear Waste; ‘Used nuclear fuel is only waste if you waste it,’ the communications director at a recycling company says https://www.theepochtimes.com/business/us-plans-to-start-recycling-nuclear-waste-5707349 Bayer wins US legal victory against Roundup cancer claims https://finance.yahoo.com/news/bayer-wins-victory-us-legal-184753409.html Pfizer, BioNTech, and Moderna Have Lost a Combined Market Capitalization of $418,887,461,200 https://dailyclout.io/pfizer-biontech-and-moderna-have-lost-a-combined-market-capitalization-of-418887461200/ WHO declares mpox a global public health emergency for second time in two years; The declaration followed an outbreak of the viral infection in the Democratic Republic of Congo that has spread to neighboring countries. https://www.nbcnews.com/health/health-news/who-declares-mpox-global-public-health-emergency-second-time-rcna166601 Will the New Monkeypox Scare be Used Against Us?; A Misunderstood Virus and the 2024 Election https://vigilantnews.com/post/will-the-new-monkeypox-scare-be-used-against-us/ Video: Government Reviews Mpox Preparedness Post WHO Warning | CNBC TV18 (Audio) https://www.youtube.com/watch?v=HZ2x5L7-oy8 #PumpUpThaVolume/#TruthMusic: Dominic Frisby – “It’s All True – A Song About Conspiracy Theories” https://youtu.be/VwSz1AF8lVM Harris campaign mandates COVID-19 vaccine for employees; If one has an accommodation, they must speak to human resources about it. https://justthenews.com/politics-policy/coronavirus/harris-campaign-mandates-covid-19-vaccine-employees Video: Harris on taking a COVID vaccine: If Trump tells us to take it, I won’t (Oct. 7, 2020 // Audio) https://www.youtube.com/watch?v=40eZeXPyJ0g Video: VP Kamala Harris Releases Message To The Unvaccinated (May 21, 2021 // Audio) https://www.youtube.com/shorts/pOHXFMZx8nc Science journal buries high myocarditis risk from COVID vax, claims shot reduces heart attacks https://justthenews.com/politics-policy/coronavirus/science-journal-buries-high-myocarditis-risk-covid-vax-claims-it Harris-Walz campaign tells @teenvogue nearly $1 million worth of camo hats were bought yesterday, an initial run of 3000 hats sold out in 30 minutes https://x.com/versharma/status/1821257750904475879 What Is Dumb May Never Die; Kamala Harris’ price-control gambit has been tried before—and found wanting https://thedispatch.com/newsletter/gfile/what-is-dumb-may-never-die/ 🛍️ Walmart’s cart conquest https://sherwood.news/snacks/newsletters/walmarts-cart-conquest/ How Food Prices Have Changed Over the Past Four Years https://www.yahoo.com/news/food-prices-changed-over-past-112929026.html Mars gobbles up maker of Corn Flakes and Pringles for £28bn https://news.sky.com/story/mars-buys-maker-of-corn-flakes-and-pringles-for-16328bn-13197007 The $5 footlong is now the $15 footlong. Customers want Subway’s old deal back.; The five-buck deal, made famous by a memorable jingle, ended in 2014. Subway’s footlongs can now run anywhere from around $8 to $15. https://www.marketwatch.com/story/the-5-footlong-is-now-the-15-footlong-customers-want-subways-old-deal-back-87ceee90 Sugar substitute erythritol may increase risk for heart attack and stroke, study finds https://www.cbsnews.com/news/erythritol-he...

[whattheabcxyz]

2024-01-21

Singapore

Claim limit for victims misled into buying financial products to increase to $150K

Plunge in number of babies born to teens as youth get more savvy about contraception

School traffic congestion in Bukit Timah still bad

Several StarHub users unable to watch TV & EPL matches due to problems logging in - sounds like typical substandard service from our $hitty ISPs

Former nurse to be charged for stealing patients’ bank card details to make unauthorised transactions

Health

25 cases of monkeypox in Singapore from Sep-Dec last year

Food

Singapore: Frustrations mounting among companies selling insects as food as SFA delays approval - I definitely won't be trying any bugs anytime soon... I think some of us evolved to be strongly repulsed by them for a very good reason 🤢

Art

^ To celebrate the 75th anniversary of Bvlgari's iconic snake design, designer Emmanuelle Moureaux created an infinity room in Tokyo

Gossip

Alec Baldwin indicted on involuntary manslaughter charge in Rust shooting - sounds terribly unfair to me, as the only people responsible should've been the idiots who prepared & checked the gun

[sufferfly1]

A Comprehensive Study on Monkeypox testing Market : Market Dynamics and Forecast

“According to the research report, the global monkeypox testing market was valued at USD 1,331.48 million in 2021 and is expected to reach USD 1,968.47 million by 2030, to grow at a CAGR of 4.5% during the forecast period.” Polaris Market Research has unveiled an updated report on Monkeypox Testing Market Share, Size, Trends, Industry Analysis Report, By Technology (PCR, LFA, Others); By End Use; By Region; Segment Forecast, 2022 – 2030, that provides a thorough analysis of the market status with the best facts and figures, definitions, applications, and the latest developments across the globe. The report assesses the industry structure based on Monkeypox Testing Market size, segments, source, distribution channel, and major regions. It scrutinizes the latest trends in the industry and studies their impact on the overall market environment. The market has evolved swiftly in recent years and has made a remarkable contribution to global finances in terms of growth rate, Monkeypox Testing Market share, and revenue generation.

Get Sample PDF with Report Insight @ https://www.polarismarketresearch.com/industry-analysis/monkeypox-testing-market/request-for-sample

Key Market Dynamics This analytical study report provides information on significant aspects of the market, such as dynamics, key demand and price, technology trends, and detailed profiles of key players, industry revenue, and regional segments analyzing the Monkeypox Testing Market based on SWOT and Porter's Five Forces models. Details of segment markets by type, application, and region have been covered in this report, with historical data presented in metrics of sales volume, revenue, and growth rate.

Key Offerings:

Industry Dynamics

Monkeypox Testing Market Segmentation

Market Size in terms of Value and Volume: Current, Historical, and Projected Data

Industrial Trends and Developments

Competitive Landscape

Opportunities in the market

Strategies and Products offerings of Major Players

Strategic Recommendations for the new entrants

Production and Consumption Analysis by Regions

Growth Prospects with Revenue Estimations

Main Findings and Insights

The next section gives a detailed description of the key drivers, restraints, growth opportunities, challenges, and risks in the market. Further, the development status and future Monkeypox Testing Market trends are tracked in the report. The supply chain and cost analysis in the report are both explained in-depth. Through technological innovation and advancement, the product's performance will be further optimized, expanding its use in downstream applications. Additionally, readers will find market dynamics and consumer behavior studies as essential data for understanding the market. Top Key Players:

Aegis Sciences Corp

BD

Chembio Diagnostics Inc.

Laboratory Corp. of America Holdings

Mayo Clinic Laboratories

QIAGEN

Quest Diagnostics Inc

Sonia Healthcare Ltd

Sonora Quest Laboratories

Thermo Fisher Scientific

Monkeypox Testing Market key players are presented along with their expansion plans, share, strategies, and business overview. In addition to this, their company profiles, sales figures, profit margins, and product and service portfolios are evaluated in the report. The chapter sheds light on the business expansion strategies employed by these players, such as mergers and acquisitions, product launches, collaborations, M&A, contracts, partnerships, and joint ventures. 

Inquire your Questions If any Before Purchasing this Report @ https://www.polarismarketresearch.com/industry-analysis/monkeypox-testing-market/inquire-before-buying

How Will This Report Help you?

The report delivers extensive analysis in the form of figures, tables, charts, and graphs combined with an in-depth study of current and future Monkeypox Testing Market prospects. It further allows readers to comprehend the competitive regional pattern by comparing the sales volume and revenue of the world's key regions. Import volume and export volume are evaluated on a regional level. Key statistical insights are presented in a straightforward manner that will users grasp the market's development patterns, crucial factors, and other loopholes which are expected to affect the market expansion.

Key Regions Covered By Report:

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and the rest of South America)

The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

The entire market industrial chain is examined in the research, from the important upstream raw materials and their suppliers to the midstream distributors and downstream customers, while taking the effects of global inflation into account. Finally, it predicts the market's future trends from the perspectives of various types, uses, and significant geographical areas. This study is a trustworthy source for market research that will greatly accelerate the growth of your business and increase its presence in the Monkeypox Testing Market. Browse Additional Details on "Monkeypox Testing Market" @ https://www.polarismarketresearch.com/industry-analysis/monkeypox-testing-market

Reasons to Purchase This Report

This research includes a thorough worldwide and regional analysis of the market.

It gives thorough coverage of every sector of the market in order to assess prospective trends, growth plans, and industry size projections.

The firm profiles of each industry player examine the industry portfolio, sales income, SWOT analysis, and current advancements.

Comprehension of the market's drivers, restrictions, and key small markets.

Analysis of collaboration and authorizing transaction trends can be used to identify commercial prospects in the market sales scenario.

The research analyzes how specific industry structures, ideas, or technological advancements may help with player promotion.

About Us

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Polaris Market Research

Email: sales@polarismarketresearch.com

Ph: +1-929 297-9727